Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population

T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for Activity

1978 • 3,314 citations

A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor

1982 • 877 citations

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

1978 • 744 citations

Expression of interleukin 2 receptors on activated human B cells.

1984 • 488 citations

Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.

1983 • 483 citations

Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

1981 • 477 citations

Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

1983 • 453 citations

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

1983 • 414 citations

Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.

1983 • 385 citations

Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.

1981 • 368 citations

Expression of Tac antigen on activated normal human B cells.

1984 • 355 citations

Enhancement by Interferon of the Specific Cytotoxicity of Sensitized Lymphocytes

1972 • 308 citations

Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes

1981 • 289 citations

In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.

1983 • 245 citations

Interferons with Special Emphasis on the Immune System

1983 • 211 citations

T Cell Helper Defect in Patients with Chronic Lymphocytic Leukemia

1979 • 197 citations

Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation

1981 • 168 citations

Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies.

1982 • 160 citations

Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon.

1980 • 130 citations

T cell factor (interleukin 2) allows in vivo induction of T helper cells against heterologous erythrocytes in athymic (nu/nu) mice

1980 • 107 citations

Clinical staging and immunological findings in chronic lymphocytic leukemia

1979 • 93 citations

Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type.

1982 • 82 citations

Increased Incidence of Neoplasia in Association with Chronic Lymphocytic Leukaemia

1969 • 62 citations

Automated, quantitative cytopathic effect reduction assay for interferon

1982 • 56 citations

Discrepancy between phenotypic and functional features of natural killer T‐lymphocytes in B‐cell chronic lymphocytic leukaemia

1984 • 50 citations

T lymphocytes in B-cell chronic lymphocytic leukemia: Characterization by monoclonal antibodies and correlation with Fc receptors

1983 • 44 citations

Lack of autologous mixed lymphocyte reaction in patients with chronic lymphocytic leukemia: evidence for autoreactive T-cell dysfunction not correlated with phenotype, karyotype, or clinical status

1982 • 33 citations

REDUCED T‐COLONY FORMING CAPACITY BY T‐LYMPHOCYTES FROM B‐CHRONIC LYMPHOCYTIC LEUKAEMIA

1980 • 32 citations

Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type.

1983 • 25 citations